These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15166624)

  • 21. Dacarbazine and fotemustine in advanced colorectal cancer.
    Tixi L; Bolli E; Guglielmi A; Mori A; Aschele C; Nobile MT; Rosso R; Sobrero A
    Eur J Cancer; 1993; 29A(3):476. PubMed ID: 8398352
    [No Abstract]   [Full Text] [Related]  

  • 22. A probable mechanism for hyperpigmentation by fotemustine.
    Schallreuter KU; Ring J
    Dermatology; 1992; 185(1):76-7. PubMed ID: 1638080
    [No Abstract]   [Full Text] [Related]  

  • 23. [Interspecies comparison of pharmacokinetic parameters of fotemustine (nitrosourea S 10036): mice, rats, monkeys, dogs and man].
    Lucas C; Ings B; Gray AJ; Deloffre P; Lokiec F; Campbell B; Beerblock K
    Bull Cancer; 1989; 76(8):863-5. PubMed ID: 2515897
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC.
    Kirstein MN; Panetta JC; Gajjar A; Nair G; Iacono LC; Freeman BB; Stewart CF
    Cancer Chemother Pharmacol; 2005 May; 55(5):433-8. PubMed ID: 15818507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical pharmacology of alkylating agents in high-dose chemotherapy.
    Huitema AD; Smits KD; Mathôt RA; Schellens JH; Rodenhuis S; Beijnen JH
    Anticancer Drugs; 2000 Aug; 11(7):515-33. PubMed ID: 11036954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma--more questions than answers?
    Reardon DA
    Nat Clin Pract Oncol; 2006 Feb; 3(2):60-1. PubMed ID: 16462825
    [No Abstract]   [Full Text] [Related]  

  • 27. Disposition, pharmacokinetics, and metabolism of 14C-fotemustine in cancer patients.
    Ings RM; Gray AJ; Taylor AR; Gordon BH; Breen M; Hiley M; Brownsill R; Marchant N; Richards R; Wallace D
    Eur J Cancer; 1990; 26(7):838-42. PubMed ID: 2145908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new method for the measurement of nitrosoureas in plasma: an h.p.l.c. procedure for the measurement of fotemustine kinetics.
    Gordon BH; Richards RP; Hiley MP; Gray AJ; Ings RM; Campbell DB
    Xenobiotica; 1989 Mar; 19(3):329-39. PubMed ID: 2665327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of alkylating agents.
    Lind MJ; Ardiet C
    Cancer Surv; 1993; 17():157-88. PubMed ID: 8137340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative diffusion study of two nitrosoureas: carmustine and fotemustine in normal rat brain, human and rat brain biopsies.
    Meulemans A; Giroux B; Hannoun P; Robine D; Henzel D
    Chemotherapy; 1991; 37(2):86-92. PubMed ID: 2032474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinical picture of glioblastoma multiforme in patients of younger age groups].
    Fischer W; Lübbe D
    Beitr Neurochir; 1968; 15():77-82. PubMed ID: 4312387
    [No Abstract]   [Full Text] [Related]  

  • 32. [Histochemistry of the tumors of the central nervous system. I. Glioblastoma multiforme].
    CALVO W; MIQUEL J
    Rev Esp Otoneurooftalmol Neurocir; 1957; 16(89):40-51. PubMed ID: 13442116
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histochemistry of tumors of the central nervous system. I. Glioblastoma multiforme].
    MIQUEL J; CALVO W
    Rev Esp Otoneurooftalmol Neurocir; 1957; 16(90):108-18. PubMed ID: 13453959
    [No Abstract]   [Full Text] [Related]  

  • 34. [First case of urticaria due to dacarbazine].
    Bourry C; Naveau C; Lazrak K; Celerier P; Pasquiou C
    Therapie; 1995; 50(6):588-9. PubMed ID: 8745961
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diffuse gliomas of the central nervous system].
    RYZHKOV EV
    Arkh Patol; 1959; 21(1):54-9. PubMed ID: 13638142
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dacarbazine].
    van Nispen tot Pannerden EB; van Sorge AA
    Ned Tijdschr Geneeskd; 1984 Dec; 128(49):2321. PubMed ID: 6514052
    [No Abstract]   [Full Text] [Related]  

  • 37. [Considerations on the factors affecting the prognosis of glioblastoma multiforme].
    ALVISI C; DAIDONE R; GAMBERINI A
    Minerva Neurochir; 1962; 6():185-7. PubMed ID: 14012426
    [No Abstract]   [Full Text] [Related]  

  • 38. [Various physiological aspects of intra-tumoral circulation in ten cases of glioblastoma multiforme].
    FASANO VA; BROGGI G
    Minerva Chir; 1955 Mar; 10(5):215-9. PubMed ID: 14369793
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rare localization and spreading of glioblastoma multiforme].
    ZEITLHOFER J
    Wien Z Nervenheilkd Grenzgeb; 1953; 8(1-2):109-23. PubMed ID: 13157422
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-induced cytochemical changes in a glioblastoma.
    Zeman W; Mealey J
    Ann Histochim; 1965; 10(2):61-9. PubMed ID: 4284962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.